Attached files

file filename
8-K - 8-K - VALIDUS HOLDINGS LTDa12-10325_38k.htm

Exhibit 99.1

 

Validus Holdings, Ltd.
Revised Segment Structure - 2011 Comparative Information
April 26, 2012

 

 

 

29 Richmond Road

 

Pembroke, HM08 Bermuda

 

Telephone: (441) 278-9000

 

Facsimile: (441) 278-9090

 

Website: www.validusholdings.com

 

Mailing address: Suite 1790 48 Par-la-Ville Road

 

Hamilton, HM11 Bermuda

 



 

Validus Holdings, Ltd.

Explanatory Notes

 

Basis of Presentation

 

·      This supplement is for information purposes only.  It should be read in conjunction with documents filed by Validus Holdings, Ltd. with the U.S. Securities and Exchange Commission pursuant to the Securities Exchange Act 1934.

 

·      All financial information contained herein is unaudited, however, certain information contained herein relating to the year ended December 31, 2011 is derived from or agrees to audited financial information.

 

·      Unless otherwise noted, dollar amounts are in thousands of U.S. dollars, except for ratio information.

 

·      On May 25, 2011, the Company joined with other investors in capitalizing AlphaCat Re 2011, Ltd. (“AlphaCat Re 2011”) a new special purpose “sidecar” reinsurer formed for the purpose of writing collateralized reinsurance and retrocessional reinsurance. The financial statements of AlphaCat Re 2011 were included in the consolidated financial statements of the Company during 2011 as Validus Re held a majority of AlphaCat Re 2011’s outstanding voting rights. The portion of AlphaCat Re 2011’s earnings attributable to third party investors for the year ended December 31, 2011 is recorded in the consolidated statement of comprehensive income as ‘net income attributable to noncontrolling interest’. On December 23, 2011 AlphaCat Re 2011 completed a secondary share offering and subsequently Validus Re sold 86,113 shares in AlphaCat Re 2011 and no longer held a majority of the outstanding voting rights and therefore had an equity method investment in AlphaCat Re 2011 as at December 31, 2011.

 

·      During the first quarter of 2012, to better align the Company’s operating and reporting structure with its current strategy, there was a change in the segment structure. This change was to include the AlphaCat group of companies as a separate operating segment. “AlphaCat segment” was included as an additional segment and includes the company’s investment in AlphaCat Re 2011. Prior period comparatives have been restated to reflect the change in segmentation.

 

Notes on Non-GAAP Measures

 

·      In presenting the Company’s results herein, management has included certain schedules containing net operating income (loss) and underwriting income (loss) that are not calculated under standards or rules that comprise U.S. GAAP. Such measures are referred to as non-GAAP. Non-GAAP measures may be defined or calculated differently by other companies. These measures should not be viewed as a substitute for those determined in accordance with U.S. GAAP. We believe that these measures are important to investors and other interested parties. These measures should not be viewed as a substitute for those determined in accordance with U.S. GAAP.

 

·      The underwriting results of an insurance or reinsurance company are often measured by reference to its underwriting income because underwriting income indicates the performance of the company’s core underwriting function.  Underwriting income is reconciled to net income by the addition or subtraction of net investment income (loss), finance expenses, transaction expenses, net realized gains (losses) on investments, net unrealized gains (losses) on investments and foreign exchange gains (losses).

 

·      Net operating income (loss) available (attributable) to Validus is calculated based on net income (loss) available (attributable) to Validus excluding net realized gains (losses), net unrealized gains (losses) on investments, gains (losses) arising from translation of non-US$ denominated balances and non-recurring items. Net income is the most directly comparable GAAP measure.  Net operating income focuses on the underlying fundamentals of our operations without the influence of realized gains (losses) from the sale of investments, net unrealized gains on investments, translation of non-US$ currencies and non-recurring items. Realized gains (losses) from the sale of investments are driven by the timing of the disposition of investments, not by our operating performance.  Gains (losses) arising from translation of non-US$ denominated balances are unrelated to our underlying business.

 

·      A reconciliation to the most comparable GAAP measure for net operating income can be found in the company’s latest earnings press release.

 



 

 

Validus Holdings, Ltd.

Consolidated Segment Income Statement - Three months ended March 31, 2011 (REPRESENTED)

(Expressed in thousands of U.S. Dollars, except share and per share information)

 

 

 

Three Months Ended March 31, 2011

 

Three Months Ended March 31, 2011

 

 

 

Validus Re
Segment (c)

 

AlphaCat
Segment 
(d)

 

Legal Entity
Adjustments

 

Validus Re
Consolidated (e)

 

Talbot Segment

 

Corporate &
Eliminations

 

Total

 

Validus Re

 

Talbot

 

Corporate &
Eliminations

 

Total

 

Underwriting income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross premiums written

 

$

604,088

 

$

7,150

 

 

$

611,238

 

$

263,057

 

$

(24,399

)

$

849,896

 

$

611,238

 

$

263,057

 

$

(24,399

)

$

849,896

 

Reinsurance premiums ceded

 

(46,805

)

 

 

(46,805

)

(87,414

)

24,399

 

(109,820

)

(46,805

)

(87,414

)

24,399

 

(109,820

)

Net premiums written

 

557,283

 

7,150

 

 

564,433

 

175,643

 

 

740,076

 

564,433

 

175,643

 

 

740,076

 

Change in unearned premiums

 

(308,340

)

(3,784

)

 

(312,124

)

1,581

 

 

(310,543

)

(312,124

)

1,581

 

 

(310,543

)

Net premiums earned

 

248,943

 

3,366

 

 

252,309

 

177,224

 

 

429,533

 

252,309

 

177,224

 

 

429,533

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Underwriting deductions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Losses and loss expenses

 

310,544

 

 

 

310,544

 

165,654

 

 

476,198

 

310,544

 

165,654

 

40,998

 

476,198

 

Policy acquisition costs

 

39,750

 

316

 

 

40,066

 

37,216

 

14

 

77,296

 

40,066

 

37,216

 

14

 

77,296

 

General and administrative expenses

 

10,657

 

894

 

1,347

 

12,898

 

28,722

 

6,857

 

48,477

 

10,657

 

28,722

 

9,098

 

48,477

 

Share compensation expenses

 

3,105

 

27

 

328

 

3,460

 

2,719

 

5,870

 

12,049

 

3,105

 

2,719

 

6,225

 

12,049

 

Total underwriting deductions

 

364,056

 

1,237

 

1,675

 

366,968

 

234,311

 

12,741

 

614,020

 

364,372

 

234,311

 

15,337

 

614,020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Underwriting (loss) income

 

$

(115,113

)

$

2,129

 

$

(1,675

)

$

(114,659

)

$

(57,087

)

$

(12,741

)

$

(184,487

)

$

(112,063

)

$

(57,087

)

$

(15,337

)

$

(184,487

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net investment income

 

24,432

 

1,219

 

 

25,651

 

6,590

 

(2,266

)

29,975

 

25,651

 

6,590

 

(2,266

)

29,975

 

Other income

 

1,418

 

641

 

230

 

2,289

 

3,017

 

(3,700

)

1,606

 

1,433

 

3,017

 

(2,844

)

1,606

 

Finance expenses

 

(1,713

)

 

 

(1,713

)

(63

)

(12,225

)

(14,001

)

(1,713

)

(63

)

(12,225

)

(14,001

)

Operating (loss) income before taxes

 

(90,976

)

3,989

 

(1,445

)

(88,432

)

(47,543

)

(30,932

)

(166,907

)

(86,692

)

(47,543

)

(32,672

)

(166,907

)

Tax (expense) benefit

 

(2

)

 

 

(2

)

1,793

 

(332

)

1,459

 

(2

)

1,793

 

(332

)

1,459

 

Net operating (loss) income (a)

 

$

(90,978

)

$

3,989

 

$

(1,445

)

$

(88,434

)

$

(45,750

)

$

(31,264

)

$

(165,448

)

$

(86,694

)

$

(45,750

)

$

(33,004

)

$

(165,448

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net realized gains on investments

 

3,901

 

18

 

 

3,919

 

2,460

 

 

6,379

 

3,919

 

2,460

 

 

6,379

 

Net unrealized (losses) on investments

 

(7,676

)

(839

)

 

(8,515

)

(4,313

)

 

(12,828

)

(8,515

)

(4,313

)

 

(12,828

)

Foreign exchange (losses) gains

 

(4,270

)

(90

)

 

(4,360

)

3,901

 

(8

)

(467

)

(4,360

)

3,901

 

(8

)

(467

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income

 

$

(99,023

)

$

3,078

 

$

(1,445

)

$

(97,390

)

$

(43,702

)

$

(31,272

)

$

(172,364

)

$

(95,650

)

$

(43,702

)

$

(33,012

)

$

(172,364

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selected ratios:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net premiums written / Gross premiums written

 

92.3

%

100.0

%

 

 

 

 

66.8

%

 

 

87.1

%

92.3

%

66.8

%

 

 

87.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Losses and loss expenses

 

124.7

%

0.0

%

 

 

 

 

93.5

%

 

 

110.9

%

123.1

%

93.5

%

 

 

110.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Policy acquisition costs

 

16.0

%

9.4

%

 

 

 

 

21.0

%

 

 

18.0

%

15.9

%

21.0

%

 

 

18.0

%

General and administrative expenses (b)

 

5.5

%

27.4

%

 

 

 

 

17.7

%

 

 

14.1

%

5.5

%

17.7

%

 

 

14.1

%

Expense ratio

 

21.5

%

36.7

%

 

 

 

 

38.7

%

 

 

32.1

%

21.4

%

38.7

%

 

 

32.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Combined ratio

 

146.2

%

36.7

%

 

 

 

 

132.2

%

 

 

143.0

%

144.5

%

132.2

%

 

 

143.0

%

 


Notes:

(a) Net operating income (loss), a non-GAAP financial measure, is defined as net income (loss) excluding net realized and unrealized gains (losses) on investments, foreign exchange gains (losses) and non-recurring items. This measure focuses on the underlying fundamentals of our operations without the influence of gains (losses) from the sale of investments, translation of non-U.S.$ currencies and non-recurring items. Gains (losses) from the sale of investments are driven by the timing of the disposition of investments, not by our operating performance. Gains (losses) arising from translation of non-U.S.$ denominated balances are unrelated to our underlying business.

 

(b) The general and administrative ratio includes share compensation expenses.

 

(c) The Validus Re Segment includes the following entities: Validus Reinsurance, Ltd., Validus Ltd., Validus Reinsurance, Ltd. (Singapore), Validus Reaseguros, Inc., Validus Re Chile S.A., Underwriting Risk Services, S.A., Validus Re Americas, Ltd. and Validus Re Europe Limited.

 

(d) The AlphatCat Segment includes the following entities: AlphaCat Fund Ltd., AlphaCat Master Fund Ltd. AlphaCat Reinsurance Ltd., AlphaCat High Return Fund Ltd., Validus Underwriting Services, Ltd., Validus Ventures Ltd., and Validus Managers Ltd.

 

(e) Validus Re Consolidated includes the following entities: Validus Reinsurance, Ltd., Validus Ltd., Validus Reinsurance, Ltd. (Singapore), Validus Specialty, Inc., Validus Reaseguros, Inc., Validus Services, Inc., Underwriting Risk Services, Inc., Validus Re Chile S.A., Validus Re Americas, Ltd., Validus Underwriting Services, Ltd., Validus Re Europe Limited; AlphaCat Fund, Ltd, AlphaCat Master Fund, Ltd., AlphaCat Reinsurance, Ltd. and AlphaCat High Return Fund Ltd.

 

4



 

 

Validus Holdings, Ltd.

Consolidated Segment Income Statement - Three months ended June 30, 2011 (REPRESENTED)

(Expressed in thousands of U.S. Dollars, except share and per share information)

 

 

 

Three Months Ended June 30, 2011

 

Three Months Ended June 30, 2011

 

 

 

Validus Re
Segment (c)

 

AlphaCat
Segment 
(d)(e)

 

Legal Entity
Adjustments

 

Validus Re
Consolidated (f)

 

Talbot Segment

 

Corporate &
Eliminations

 

Total

 

Validus Re

 

Talbot

 

Corporate &
Eliminations

 

Total

 

Underwriting income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross premiums written

 

$

290,691

 

$

50,960

 

 

$

341,651

 

$

276,886

 

$

(13,150

)

$

605,387

 

$

341,651

 

$

276,886

 

$

(13,150

)

$

605,387

 

Reinsurance premiums ceded

 

(98,218

)

 

 

(98,218

)

(47,278

)

13,150

 

(132,346

)

(98,218

)

(47,278

)

13,150

 

(132,346

)

Net premiums written

 

192,473

 

50,960

 

 

243,433

 

229,608

 

 

473,041

 

243,433

 

229,608

 

 

473,041

 

Change in unearned premiums

 

31,814

 

(42,569

)

 

(10,755

)

(36,646

)

 

(47,401

)

(10,755

)

(36,646

)

 

(47,401

)

Net premiums earned

 

224,287

 

8,391

 

 

232,678

 

192,962

 

 

425,640

 

232,678

 

192,962

 

 

425,640

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Underwriting deductions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Losses and loss expenses

 

94,035

 

 

 

94,035

 

113,272

 

 

207,307

 

94,035

 

113,272

 

40,998

 

207,307

 

Policy acquisition costs

 

35,013

 

973

 

(217

)

35,769

 

42,307

 

154

 

78,230

 

35,769

 

42,307

 

154

 

78,230

 

General and administrative expenses

 

15,167

 

1,061

 

1,813

 

18,041

 

34,718

 

8,082

 

60,841

 

15,458

 

34,718

 

10,665

 

60,841

 

Share compensation expenses

 

1,823

 

21

 

174

 

2,018

 

2,026

 

3,584

 

7,628

 

1,823

 

2,026

 

3,779

 

7,628

 

Total underwriting deductions

 

146,038

 

2,055

 

1,770

 

149,863

 

192,323

 

11,820

 

354,006

 

147,085

 

192,323

 

14,598

 

354,006

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Underwriting income (loss)

 

$

78,249

 

$

6,336

 

$

(1,770

)

$

82,815

 

$

639

 

$

(11,820

)

$

71,634

 

$

85,593

 

$

639

 

$

(14,598

)

$

71,634

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net investment income

 

21,662

 

727

 

 

22,389

 

6,372

 

(2,267

)

26,494

 

22,389

 

6,372

 

(2,267

)

26,494

 

Other income

 

853

 

2,532

 

(308

)

3,077

 

1,967

 

(4,449

)

595

 

854

 

1,967

 

(2,226

)

595

 

Finance expenses

 

(1,579

)

(2,923

)

 

(4,502

)

 

(11,859

)

(16,361

)

(4,502

)

 

(11,859

)

(16,361

)

Operating income (loss) before taxes

 

99,185

 

6,672

 

(2,078

)

103,779

 

8,978

 

(30,395

)

82,362

 

104,334

 

8,978

 

(30,950

)

82,362

 

Tax (expense) benefit

 

(4

)

 

 

(4

)

(208

)

241

 

29

 

(4

)

(208

)

241

 

29

 

Net operating income (loss) (a)

 

$

99,181

 

$

6,672

 

$

(2,078

)

$

103,775

 

$

8,770

 

$

(30,154

)

$

82,391

 

$

104,330

 

$

8,770

 

$

(30,709

)

$

82,391

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net realized gains on investments

 

9,014

 

538

 

 

9,552

 

2,000

 

 

11,552

 

9,552

 

2,000

 

 

11,552

 

Net unrealized gains (losses) on investments

 

15,377

 

(820

)

 

14,557

 

3,969

 

 

18,526

 

14,557

 

3,969

 

 

18,526

 

Foreign exchange (losses) gains

 

(5,266

)

(71

)

 

(5,337

)

3,410

 

(64

)

(1,991

)

(5,337

)

3,410

 

(64

)

(1,991

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

118,306

 

$

6,319

 

$

(2,078

)

$

122,547

 

$

18,149

 

$

(30,218

)

$

110,478

 

$

123,102

 

$

18,149

 

$

(30,773

)

$

110,478

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to noncontrolling interest

 

 

(594

)

 

(594

)

 

 

(594

)

(594

)

 

 

(594

)

Net income (loss) available (attributable) to Validus

 

$

118,306

 

$

5,725

 

$

(2,078

)

$

121,953

 

$

18,149

 

$

(30,218

)

$

109,884

 

$

122,508

 

$

18,149

 

$

(30,773

)

$

109,884

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selected ratios:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net premiums written / Gross premiums written

 

66.2

%

100.0

%

 

 

 

 

82.9

%

 

 

78.1

%

71.3

%

82.9

%

 

 

78.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Losses and loss expenses

 

41.9

%

0.0

%

 

 

 

 

58.7

%

 

 

48.7

%

40.4

%

58.7

%

 

 

48.7

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Policy acquisition costs

 

15.6

%

11.6

%

 

 

 

 

21.9

%

 

 

18.4

%

15.4

%

21.9

%

 

 

18.4

%

General and administrative expenses (b)

 

7.6

%

12.9

%

 

 

 

 

19.0

%

 

 

16.1

%

7.4

%

19.0

%

 

 

16.1

%

Expense ratio

 

23.2

%

24.5

%

 

 

 

 

40.9

%

 

 

34.5

%

22.8

%

40.9

%

 

 

34.5

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Combined ratio

 

65.1

%

24.5

%

 

 

 

 

99.5

%

 

 

83.2

%

63.2

%

99.6

%

 

 

83.2

%

 


Notes:

(a) Net operating income (loss), a non-GAAP financial measure, is defined as net income (loss) excluding net realized and unrealized gains (losses) on investments, foreign exchange gains (losses) and non-recurring items. This measure focuses on the underlying fundamentals of our operations without the influence of gains (losses) from the sale of investments, translation of non-U.S.$ currencies and non-recurring items. Gains (losses) from the sale of investments are driven by the timing of the disposition of investments, not by our operating performance. Gains (losses) arising from translation of non-U.S.$ denominated balances are unrelated to our underlying business.

 

(b) The general and administrative ratio includes share compensation expenses.

 

(c) The Validus Re Segment includes the following entities: Validus Reinsurance, Ltd., Validus Ltd., Validus Reinsurance, Ltd. (Singapore), Validus Reaseguros, Inc., Validus Re Chile S.A., Underwriting Risk Services, S.A., Validus Re Americas, Ltd. and Validus Re Europe Limited.

 

(d) The AlphatCat Segment includes the following entities: AlphaCat Fund Ltd., AlphaCat Master Fund Ltd. AlphaCat Reinsurance Ltd., AlphaCat High Return Fund Ltd., AlphaCat Re 2011, Ltd., Validus Underwriting Services, Ltd., Validus Ventures Ltd., and Validus Managers Ltd.

 

(e) On May 25, 2011, the Company joined with other investors in capitalizing AlphaCat Re 2011, Ltd. (“AlphaCat Re 2011”) a new special purpose “sidecar” reinsurer formed for the purpose of writing collateralized reinsurance and retrocessional reinsurance. The financial statements of AlphaCat Re 2011 were included in the consolidated financial statements of the Company beginning in the second quarter of 2011 as Validus Re held a majority of AlphaCat Re 2011’s outstanding voting rights. The portion of AlphaCat Re 2011’s earnings attributable to third party investors for the year ended December 31, 2011 is recorded in the consolidated statement of operations and comprehensive income as ‘net income attributable to noncontrolling interest’. On December 23, 2011 AlphaCat Re 2011 completed a secondary share offering and subsequently Validus Re sold 86,113 shares in AlphaCat Re 2011 and no longer held a majority of the outstanding voting rights and therefore had an equity method investment in AlphaCat Re 2011 as at December 31, 2011.

 

(f) Validus Re Consolidated includes the following entities: Validus Reinsurance, Ltd., Validus Ltd., Validus Reinsurance, Ltd. (Singapore), Validus Specialty, Inc., Validus Reaseguros, Inc., Validus Services, Inc., Underwriting Risk Services, Inc., Validus Re Chile S.A., Validus Re Americas, Ltd., Validus Underwriting Services, Ltd., Validus Re Europe Limited; AlphaCat Fund, Ltd, AlphaCat Master Fund, Ltd., AlphaCat Reinsurance, Ltd., AlphaCat High Return Fund Ltd., and AlphaCat Re 2011, Ltd.

 

5



 

 

Validus Holdings, Ltd.

Consolidated Segment Income Statement - Six months ended June 30, 2011 (REPRESENTED)

(Expressed in thousands of U.S. Dollars, except share and per share information)

 

 

 

Six Months Ended June 30, 2011

 

Six Months Ended June 30, 2011

 

 

 

Validus Re
Segment (c)

 

AlphaCat
Segment 
(d)(e)

 

Legal Entity
Adjustments

 

Validus Re
Consolidated (f)

 

Talbot Segment

 

Corporate &
Eliminations

 

Total

 

Validus Re

 

Talbot

 

Corporate &
Eliminations

 

Total

 

Underwriting income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross premiums written

 

$

894,779

 

$

58,110

 

 

$

952,889

 

$

539,943

 

$

(37,549

)

$

1,455,283

 

$

952,889

 

$

539,943

 

$

(37,549

)

$

1,455,283

 

Reinsurance premiums ceded

 

(145,023

)

 

 

(145,023

)

(134,692

)

37,549

 

(242,166

)

(145,023

)

(134,692

)

37,549

 

(242,166

)

Net premiums written

 

749,756

 

58,110

 

 

807,866

 

405,251

 

 

1,213,117

 

807,866

 

405,251

 

 

1,213,117

 

Change in unearned premiums

 

(276,526

)

(46,353

)

 

(322,879

)

(35,065

)

 

(357,944

)

(322,879

)

(35,065

)

 

(357,944

)

Net premiums earned

 

473,230

 

11,757

 

 

484,987

 

370,186

 

 

855,173

 

484,987

 

370,186

 

 

855,173

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Underwriting deductions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Losses and loss expenses

 

404,579

 

 

 

404,579

 

278,926

 

 

683,505

 

404,579

 

278,926

 

40,998

 

683,505

 

Policy acquisition costs

 

74,763

 

1,289

 

(217

)

75,835

 

79,523

 

168

 

155,526

 

75,835

 

79,523

 

168

 

155,526

 

General and administrative expenses

 

25,824

 

1,955

 

3,160

 

30,939

 

63,440

 

14,939

 

109,318

 

26,115

 

63,440

 

19,763

 

109,318

 

Share compensation expenses

 

4,928

 

48

 

502

 

5,478

 

4,745

 

9,454

 

19,677

 

4,928

 

4,745

 

10,004

 

19,677

 

Total underwriting deductions

 

510,094

 

3,292

 

3,445

 

516,831

 

426,634

 

24,561

 

968,026

 

511,457

 

426,634

 

29,935

 

968,026

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Underwriting (loss) income

 

$

(36,864

)

$

8,465

 

$

(3,445

)

$

(31,844

)

$

(56,448

)

$

(24,561

)

$

(112,853

)

$

(26,470

)

$

(56,448

)

$

(29,935

)

$

(112,853

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net investment income

 

46,094

 

1,946

 

 

48,040

 

12,962

 

(4,533

)

56,469

 

48,040

 

12,962

 

(4,533

)

56,469

 

Other income

 

2,271

 

3,173

 

(78

)

5,366

 

4,984

 

(8,149

)

2,201

 

2,287

 

4,984

 

(5,070

)

2,201

 

Finance expenses

 

(3,292

)

(2,923

)

 

(6,215

)

(63

)

(24,084

)

(30,362

)

(6,215

)

(63

)

(24,084

)

(30,362

)

Operating income (loss) before taxes

 

8,209

 

10,661

 

(3,523

)

15,347

 

(38,565

)

(61,327

)

(84,545

)

17,642

 

(38,565

)

(63,622

)

(84,545

)

Tax (expense) benefit

 

(6

)

 

 

(6

)

1,585

 

(91

)

1,488

 

(6

)

1,585

 

(91

)

1,488

 

Net operating income (loss) (a)

 

$

8,203

 

$

10,661

 

$

(3,523

)

$

15,341

 

$

(36,980

)

$

(61,418

)

$

(83,057

)

$

17,636

 

$

(36,980

)

$

(63,713

)

$

(83,057

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net realized gains on investments

 

12,915

 

556

 

 

13,471

 

4,460

 

 

17,931

 

13,471

 

4,460

 

 

17,931

 

Net unrealized gains (losses) on investments

 

7,701

 

(1,659

)

 

6,042

 

(344

)

 

5,698

 

6,042

 

(344

)

 

5,698

 

Foreign exchange (losses) gains

 

(9,536

)

(161

)

 

(9,697

)

7,311

 

(72

)

(2,458

)

(9,697

)

7,311

 

(72

)

(2,458

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

19,283

 

$

9,397

 

$

(3,523

)

$

25,157

 

$

(25,553

)

$

(61,490

)

$

(61,886

)

$

27,452

 

$

(25,553

)

$

(63,785

)

$

(61,886

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to noncontrolling interest

 

 

(594

)

 

(594

)

 

 

(594

)

(594

)

 

 

(594

)

Net income (loss) available (attributable) to Validus

 

$

19,283

 

$

8,803

 

$

(3,523

)

$

24,563

 

$

(25,553

)

$

(61,490

)

$

(62,480

)

$

26,858

 

$

(25,553

)

$

(63,785

)

$

(62,480

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selected ratios:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net premiums written / Gross premiums written

 

83.8

%

100.0

%

 

 

 

 

75.1

%

 

 

83.4

%

84.8

%

75.1

%

 

 

83.4

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Losses and loss expenses

 

85.5

%

0.0

%

 

 

 

 

75.3

%

 

 

79.9

%

83.4

%

75.3

%

 

 

79.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Policy acquisition costs

 

15.8

%

11.0

%

 

 

 

 

21.5

%

 

 

18.2

%

15.6

%

21.5

%

 

 

18.2

%

General and administrative expenses (b)

 

6.5

%

17.0

%

 

 

 

 

18.4

%

 

 

15.1

%

6.4

%

18.4

%

 

 

15.1

%

Expense ratio

 

22.3

%

28.0

%

 

 

 

 

39.9

%

 

 

33.3

%

22.0

%

39.9

%

 

 

33.3

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Combined ratio

 

107.8

%

28.0

%

 

 

 

 

115.2

%

 

 

113.2

%

105.4

%

115.2

%

 

 

113.2

%

 


Notes:

(a) Net operating income (loss), a non-GAAP financial measure, is defined as net income (loss) excluding net realized and unrealized gains (losses) on investments, foreign exchange gains (losses) and non-recurring items. This measure focuses on the underlying fundamentals of our operations without the influence of gains (losses) from the sale of investments, translation of non-U.S.$ currencies and non-recurring items. Gains (losses) from the sale of investments are driven by the timing of the disposition of investments, not by our operating performance. Gains (losses) arising from translation of non-U.S.$ denominated balances are unrelated to our underlying business.

 

(b) The general and administrative ratio includes share compensation expenses.

 

(c) The Validus Re Segment includes the following entities: Validus Reinsurance, Ltd., Validus Ltd., Validus Reinsurance, Ltd. (Singapore), Validus Reaseguros, Inc., Validus Re Chile S.A., Underwriting Risk Services, S.A., Validus Re Americas, Ltd. and Validus Re Europe Limited.

 

(d) The AlphatCat Segment includes the following entities: AlphaCat Fund Ltd., AlphaCat Master Fund Ltd. AlphaCat Reinsurance Ltd., AlphaCat High Return Fund Ltd., AlphaCat Re 2011, Ltd., Validus Underwriting Services, Ltd., Validus Ventures Ltd., and Validus Managers Ltd.

 

(e) On May 25, 2011, the Company joined with other investors in capitalizing AlphaCat Re 2011, Ltd. (“AlphaCat Re 2011”) a new special purpose “sidecar” reinsurer formed for the purpose of writing collateralized reinsurance and retrocessional reinsurance. The financial statements of AlphaCat Re 2011 were included in the consolidated financial statements of the Company beginning in the second quarter of 2011 as Validus Re held a majority of AlphaCat Re 2011’s outstanding voting rights. The portion of AlphaCat Re 2011’s earnings attributable to third party investors for the year ended December 31, 2011 is recorded in the consolidated statement of operations and comprehensive income as ‘net income attributable to noncontrolling interest’. On December 23, 2011 AlphaCat Re 2011 completed a secondary share offering and subsequently Validus Re sold 86,113 shares in AlphaCat Re 2011 and no longer held a majority of the outstanding voting rights and therefore had an equity method investment in AlphaCat Re 2011 as at December 31, 2011.

 

(f) Validus Re Consolidated includes the following entities: Validus Reinsurance, Ltd., Validus Ltd., Validus Reinsurance, Ltd. (Singapore), Validus Specialty, Inc., Validus Reaseguros, Inc., Validus Services, Inc., Underwriting Risk Services, Inc., Validus Re Chile S.A., Validus Re Americas, Ltd., Validus Underwriting Services, Ltd., Validus Re Europe Limited; AlphaCat Fund, Ltd, AlphaCat Master Fund, Ltd., AlphaCat Reinsurance, Ltd., AlphaCat High Return Fund Ltd., and AlphaCat Re 2011, Ltd.

 

6



 

 

Validus Holdings, Ltd.

Consolidated Segment Income Statement - Three months ended September 30, 2011 (REPRESENTED)

(Expressed in thousands of U.S. Dollars, except share and per share information)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30, 2011

 

Three Months Ended September 30, 2011

 

 

 

Validus Re
Segment (d)

 

AlphaCat
Segment 
(e)(f)

 

Legal Entity
Adjustments

 

Validus Re
Consolidated (g)

 

Talbot Segment

 

Corporate &
Eliminations

 

Total

 

Validus Re

 

Talbot

 

Corporate &
Eliminations

 

Total

 

Underwriting income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross premiums written

 

$

163,863

 

$

18,940

 

 

$

182,803

 

$

238,937

 

$

(30,611

)

$

391,129

 

$

182,803

 

$

238,937

 

$

(30,611

)

$

391,129

 

Reinsurance premiums ceded

 

(5,646

)

 

 

(5,646

)

(55,551

)

30,611

 

(30,586

)

(5,646

)

(55,551

)

30,611

 

(30,586

)

Net premiums written

 

158,217

 

18,940

 

 

177,157

 

183,386

 

 

360,543

 

177,157

 

183,386

 

 

360,543

 

Change in unearned premiums

 

81,997

 

8,758

 

 

90,755

 

7,326

 

 

98,081

 

90,755

 

7,326

 

 

98,081

 

Net premiums earned

 

240,214

 

27,698

 

 

267,912

 

190,712

 

 

458,624

 

267,912

 

190,712

 

 

458,624

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Underwriting deductions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Losses and loss expenses

 

128,823

 

 

 

128,823

 

97,244

 

 

226,067

 

128,823

 

97,244

 

40,998

 

226,067

 

Policy acquisition costs

 

40,592

 

3,326

 

(1,084

)

42,834

 

36,651

 

(2,080

)

77,405

 

42,834

 

36,651

 

(2,080

)

77,405

 

General and administrative expenses

 

7,468

 

2,167

 

620

 

10,255

 

23,164

 

2,507

 

35,926

 

8,129

 

23,164

 

4,633

 

35,926

 

Share compensation expenses

 

2,190

 

26

 

284

 

2,500

 

1,903

 

2,979

 

7,382

 

2,190

 

1,903

 

3,289

 

7,382

 

Total underwriting deductions

 

179,073

 

5,519

 

(180

)

184,412

 

158,962

 

3,406

 

346,780

 

181,976

 

158,962

 

5,842

 

346,780

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Underwriting income (loss)

 

$

61,141

 

$

22,179

 

$

180

 

$

83,500

 

$

31,750

 

$

(3,406

)

$

111,844

 

$

85,936

 

$

31,750

 

$

(5,842

)

$

111,844

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net investment income

 

22,807

 

751

 

 

23,558

 

6,451

 

(2,262

)

27,747

 

23,557

 

6,451

 

(2,261

)

27,747

 

Other income

 

2,297

 

2,225

 

(1,102

)

3,420

 

1,418

 

(4,838

)

 

2,297

 

1,418

 

(3,715

)

 

Finance expenses

 

(2,632

)

787

 

 

(1,845

)

(151

)

(8,939

)

(10,935

)

(697

)

(151

)

(10,087

)

(10,935

)

Operating income (loss) before taxes

 

83,613

 

25,942

 

(922

)

108,633

 

39,468

 

(19,445

)

128,656

 

111,093

 

39,468

 

(21,905

)

128,656

 

Tax (expense)

 

(7

)

 

 

(7

)

(2,345

)

(186

)

(2,538

)

(7

)

(2,345

)

(186

)

(2,538

)

Net operating income (loss) (a)

 

$

83,606

 

$

25,942

 

$

(922

)

$

108,626

 

$

37,123

 

$

(19,631

)

$

126,118

 

$

111,086

 

$

37,123

 

$

(22,091

)

$

126,118

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net realized gains (losses) on investments

 

4,538

 

(25

)

 

4,513

 

733

 

 

5,246

 

4,513

 

733

 

 

5,246

 

Net unrealized (losses) gains on investments

 

(26,298

)

324

 

 

(25,974

)

(1,875

)

1

 

(27,848

)

(25,973

)

(1,875

)

 

(27,848

)

Foreign exchange (losses)

 

(9,778

)

(164

)

 

(9,942

)

(9,943

)

(47

)

(19,932

)

(9,942

)

(9,943

)

(47

)

(19,932

)

Transaction expenses (c)

 

 

 

 

 

 

(13,583

)

(13,583

)

 

 

(13,583

)

(13,583

)

Net income (loss)

 

$

52,068

 

$

26,077

 

$

(922

)

$

77,223

 

$

26,038

 

$

(33,260

)

$

70,001

 

$

79,684

 

$

26,038

 

$

(35,721

)

$

70,001

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to noncontrolling interest

 

 

(13,516

)

 

(13,516

)

 

 

(13,516

)

(13,516

)

 

 

(13,516

)

Net income (loss) available (attributable) to Validus

 

$

52,068

 

$

12,561

 

$

(922

)

$

63,707

 

$

26,038

 

$

(33,260

)

$

56,485

 

$

66,168

 

$

26,038

 

$

(35,721

)

$

56,485

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selected ratios:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net premiums written / Gross premiums written

 

96.6

%

100.0

%

 

 

 

 

76.8

%

 

 

92.2

%

96.9

%

76.8

%

 

 

92.2

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Losses and loss expenses

 

53.6

%

0.0

%

 

 

 

 

51.0

%

 

 

49.3

%

48.1

%

51.0

%

 

 

49.3

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Policy acquisition costs

 

16.9

%

12.0

%

 

 

 

 

19.2

%

 

 

16.9

%

16.0

%

19.2

%

 

 

16.9

%

General and administrative expenses (b)

 

4.0

%

7.9

%

 

 

 

 

13.1

%

 

 

9.4

%

3.9

%

13.1

%

 

 

9.4

%

Expense ratio

 

20.9

%

19.9

%

 

 

 

 

32.3

%

 

 

26.3

%

19.8

%

32.3

%

 

 

26.3

%

Combined ratio

 

74.5

%

19.9

%

 

 

 

 

83.3

%

 

 

75.6

%

67.9

%

83.3

%

 

 

75.6

%

 


Notes:

(a) Net operating income (loss), a non-GAAP financial measure, is defined as net income (loss) excluding net realized and unrealized gains (losses) on investments, foreign exchange gains (losses) and non-recurring items. This measure focuses on the underlying fundamentals of our operations without the influence of gains (losses) from the sale of investments, translation of non-U.S.$ currencies and non-recurring items. Gains (losses) from the sale of investments are driven by the timing of the disposition of investments, not by our operating performance. Gains (losses) arising from translation of non-U.S.$ denominated balances are unrelated to our underlying business.

 

(b) The general and administrative ratio includes share compensation expenses.

 

(c) The transaction expenses relate to costs incurred in connection with the Company’s proposed acquisition of Transatlantic Holdings, Inc. Transaction expenses are primarily comprised of legal, financial advisory and audit related services.

 

(d) The Validus Re Segment includes the following entities: Validus Reinsurance, Ltd., Validus Ltd., Validus Reinsurance, Ltd. (Singapore), Validus Reaseguros, Inc., Validus Re Chile S.A., Underwriting Risk Services, S.A., Validus Re Americas, Ltd. and Validus Re Europe Limited.

 

(e) The AlphatCat Segment includes the following entities: AlphaCat Fund Ltd., AlphaCat Master Fund Ltd. AlphaCat Reinsurance Ltd., AlphaCat High Return Fund Ltd., AlphaCat Re 2011, Ltd., Validus Underwriting Services, Ltd., Validus Ventures Ltd., and Validus Managers Ltd.

 

(f) On May 25, 2011, the Company joined with other investors in capitalizing AlphaCat Re 2011, Ltd. (“AlphaCat Re 2011”) a new special purpose “sidecar” reinsurer formed for the purpose of writing collateralized reinsurance and retrocessional reinsurance. The financial statements of AlphaCat Re 2011 were included in the consolidated financial statements of the Company beginning in the second quarter of 2011 as Validus Re held a majority of AlphaCat Re 2011’s outstanding voting rights. The portion of AlphaCat Re 2011’s earnings attributable to third party investors for the year ended December 31, 2011 is recorded in the consolidated statement of operations and comprehensive income as ‘net income attributable to noncontrolling interest’. On December 23, 2011 AlphaCat Re 2011 completed a secondary share offering and subsequently Validus Re sold 86,113 shares in AlphaCat Re 2011 and no longer held a majority of the outstanding voting rights and therefore had an equity method investment in AlphaCat Re 2011 as at December 31, 2011.

 

(g) Validus Re Consolidated includes the following entities: Validus Reinsurance, Ltd., Validus Ltd., Validus Reinsurance, Ltd. (Singapore), Validus Specialty, Inc., Validus Reaseguros, Inc., Validus Services, Inc., Underwriting Risk Services, Inc., Validus Re Chile S.A., Validus Re Americas, Ltd., Validus Underwriting Services, Ltd., Validus Re Europe Limited; AlphaCat Fund, Ltd, AlphaCat Master Fund, Ltd., AlphaCat Reinsurance, Ltd., AlphaCat High Return Fund Ltd., and AlphaCat Re 2011, Ltd.

 

7



 

 

Validus Holdings, Ltd.

Consolidated Segment Income Statement - Nine months ended September 30, 2011 (REPRESENTED)

(Expressed in thousands of U.S. Dollars, except share and per share information)

 

 

 

Nine Months Ended September 30, 2011

 

Nine Months Ended September 30, 2011

 

 

 

Validus Re
Segment (d)

 

AlphaCat
Segment (e)(f)

 

Legal Entity
Adjustments

 

Validus Re
Consolidated (g)

 

Talbot Segment

 

Corporate &
Eliminations

 

Total

 

Validus Re

 

Talbot

 

Corporate &
Eliminations

 

Total

 

Underwriting income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross premiums written

 

$

1,058,642

 

$

77,050

 

 

$

1,135,692

 

$

778,880

 

$

(68,160

)

$

1,846,412

 

$

1,135,692

 

$

778,880

 

$

(68,160

)

$

1,846,412

 

Reinsurance premiums ceded

 

(150,669

)

 

 

(150,669

)

(190,243

)

68,160

 

(272,752

)

(150,669

)

(190,243

)

68,160

 

(272,752

)

Net premiums written

 

907,973

 

77,050

 

 

985,023

 

588,637

 

 

1,573,660

 

985,023

 

588,637

 

 

1,573,660

 

Change in unearned premiums

 

(194,529

)

(37,595

)

 

(232,124

)

(27,739

)

 

(259,863

)

(232,124

)

(27,739

)

 

(259,863

)

Net premiums earned

 

713,444

 

39,455

 

 

752,899

 

560,898

 

 

1,313,797

 

752,899

 

560,898

 

 

1,313,797

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Underwriting deductions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Losses and loss expenses

 

533,402

 

 

 

533,402

 

376,170

 

 

909,572

 

533,402

 

376,170

 

40,998

 

909,572

 

Policy acquisition costs

 

115,355

 

4,615

 

(1,301

)

118,669

 

116,174

 

(1,912

)

232,931

 

118,669

 

116,174

 

(1,912

)

232,931

 

General and administrative expenses

 

33,292

 

4,122

 

3,780

 

41,194

 

86,604

 

17,446

 

145,244

 

34,244

 

86,604

 

24,396

 

145,244

 

Share compensation expenses

 

7,118

 

74

 

786

 

7,978

 

6,648

 

12,433

 

27,059

 

7,118

 

6,648

 

13,293

 

27,059

 

Total underwriting deductions

 

689,167

 

8,811

 

3,265

 

701,243

 

585,596

 

27,967

 

1,314,806

 

693,433

 

585,596

 

35,777

 

1,314,806

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Underwriting income (loss)

 

$

24,277

 

$

30,644

 

$

(3,265

)

$

51,656

 

$

(24,698

)

$

(27,967

)

$

(1,009

)

$

59,466

 

$

(24,698

)

$

(35,777

)

$

(1,009

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net investment income

 

68,901

 

2,697

 

 

71,598

 

19,413

 

(6,795

)

84,216

 

71,597

 

19,413

 

(6,794

)

84,216

 

Other income

 

4,568

 

5,398

 

(1,180

)

8,786

 

6,402

 

(12,987

)

2,201

 

4,584

 

6,402

 

(8,785

)

2,201

 

Finance expenses

 

(5,924

)

(2,136

)

 

(8,060

)

(214

)

(33,023

)

(41,297

)

(6,912

)

(214

)

(34,171

)

(41,297

)

Operating income (loss) before taxes

 

91,822

 

36,603

 

(4,445

)

123,980

 

903

 

(80,772

)

44,111

 

128,735

 

903

 

(85,527

)

44,111

 

Tax (expense)

 

(13

)

 

 

(13

)

(760

)

(277

)

(1,050

)

(13

)

(760

)

(277

)

(1,050

)

Net operating income (loss) (a)

 

$

91,809

 

$

36,603

 

$

(4,445

)

$

123,967

 

$

143

 

$

(81,049

)

$

43,061

 

$

128,722

 

$

143

 

$

(85,804

)

$

43,061

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net realized gains on investments

 

17,453

 

531

 

 

17,984

 

5,193

 

 

23,177

 

17,984

 

5,193

 

 

23,177

 

Net unrealized (losses) gains on investments

 

(18,597

)

(1,335

)

 

(19,932

)

(2,219

)

1

 

(22,150

)

(19,931

)

(2,219

)

 

(22,150

)

Foreign exchange (losses)

 

(19,314

)

(325

)

 

(19,639

)

(2,632

)

(119

)

(22,390

)

(19,639

)

(2,632

)

(119

)

(22,390

)

Transaction expenses (c)

 

 

 

 

 

 

(13,583

)

(13,583

)

 

 

(13,583

)

(13,583

)

Net income (loss)

 

$

71,351

 

$

35,474

 

$

(4,445

)

$

102,380

 

$

485

 

$

(94,750

)

$

8,115

 

$

107,136

 

$

485

 

$

(99,506

)

$

8,115

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to noncontrolling interest

 

 

(14,110

)

 

(14,110

)

 

 

(14,110

)

(14,110

)

 

 

(14,110

)

Net income (loss) available (attributable) to Validus

 

$

71,351

 

$

21,364

 

$

(4,445

)

$

88,270

 

$

485

 

$

(94,750

)

$

(5,995

)

$

93,026

 

$

485

 

$

(99,506

)

$

(5,995

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selected ratios:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net premiums written / Gross premiums written

 

85.8

%

100.0

%

 

 

 

 

75.6

%

 

 

85.2

%

86.7

%

75.6

%

 

 

85.2

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Losses and loss expenses

 

74.8

%

0.0

%

 

 

 

 

67.1

%

 

 

69.2

%

70.8

%

67.1

%

 

 

69.2

%

Policy acquisition costs

 

16.2

%

11.7

%

 

 

 

 

20.7

%

 

 

17.7

%

15.8

%

20.7

%

 

 

17.7

%

General and administrative expenses (b)

 

5.7

%

10.6

%

 

 

 

 

16.6

%

 

 

13.1

%

5.5

%

16.6

%

 

 

13.1

%

Expense ratio

 

21.9

%

22.3

%

 

 

 

 

37.3

%

 

 

30.8

%

21.3

%

37.3

%

 

 

30.8

%

Combined ratio

 

96.7

%

22.3

%

 

 

 

 

104.4

%

 

 

100.0

%

92.1

%

104.4

%

 

 

100.0

%

 


Notes:

(a) Net operating income (loss),  a non-GAAP financial measure, is defined as net income (loss) excluding net realized and unrealized gains (losses) on investments, foreign exchange gains (losses) and non-recurring items. This measure focuses on the underlying fundamentals of our operations without the influence of gains (losses) from the sale of investments, translation of non-U.S.$ currencies and non-recurring items. Gains (losses) from the sale of investments are driven by the timing of the disposition of investments, not by our operating performance. Gains (losses) arising from translation of non-U.S.$ denominated balances are unrelated to our underlying business.

 

(b) The general and administrative ratio includes share compensation expenses.

 

(c) The transaction expenses relate to costs incurred in connection with the Company’s proposed acquisition of Transatlantic Holdings, Inc. Transaction expenses are primarily comprised of legal, financial advisory and audit related services.

 

(d) The Validus Re Segment includes the following entities:  Validus Reinsurance, Ltd., Validus Ltd., Validus Reinsurance, Ltd. (Singapore), Validus Reaseguros, Inc., Validus Re Chile S.A., Underwriting Risk Services, S.A., Validus Re Americas, Ltd. and Validus Re Europe Limited.

 

(e) The AlphatCat Segment includes the following entities:  AlphaCat Fund Ltd., AlphaCat Master Fund Ltd. AlphaCat Reinsurance Ltd., AlphaCat High Return Fund Ltd., AlphaCat Re 2011, Ltd., Validus Underwriting Services, Ltd., Validus Ventures Ltd., and Validus Managers Ltd.

 

(f) On May 25, 2011, the Company joined with other investors in capitalizing AlphaCat Re 2011, Ltd. (“AlphaCat Re 2011”) a new special purpose “sidecar” reinsurer formed for the purpose of writing collateralized reinsurance and retrocessional reinsurance. The financial statements of AlphaCat Re 2011 were included in the consolidated financial statements of the Company beginning in the second quarter of 2011 as Validus Re held a majority of AlphaCat Re 2011’s outstanding voting rights. The portion of AlphaCat Re 2011’s earnings attributable to third party investors for the year ended December 31, 2011 is recorded in the consolidated statement of operations and comprehensive income as ‘net income attributable to noncontrolling interest’. On December 23, 2011 AlphaCat Re 2011 completed a secondary share offering and subsequently Validus Re sold 86,113 shares in AlphaCat Re 2011 and no longer held a majority of the outstanding voting rights and therefore had an equity method investment in AlphaCat Re 2011 as at December 31, 2011.

 

(g) Validus Re Consolidated includes the following entities: Validus Reinsurance, Ltd., Validus Ltd., Validus Reinsurance, Ltd. (Singapore), Validus Specialty, Inc., Validus Reaseguros, Inc., Validus Services, Inc., Underwriting Risk Services, Inc., Validus Re Chile S.A., Validus Re Americas, Ltd., Validus Underwriting Services, Ltd., Validus Re Europe Limited; AlphaCat Fund, Ltd, AlphaCat Master Fund, Ltd., AlphaCat Reinsurance, Ltd., AlphaCat High Return Fund Ltd., and AlphaCat Re 2011, Ltd.

 

8



 

 

Validus Holdings, Ltd.

Consolidated Segment Income Statement - Three months ended December 31, 2011 (REPRESENTED)

(Expressed in thousands of U.S. Dollars, except share and per share information)

 

 

 

Three Months Ended December 31, 2011

 

Three Months Ended December 31, 2011

 

 

 

Validus Re
Segment (d)

 

AlphaCat
Segment 
(e)(f)

 

Legal Entity
Adjustments

 

Validus Re
Consolidated (g)

 

Talbot Segment

 

Corporate &
Eliminations

 

Total

 

Validus Re

 

Talbot

 

Corporate &
Eliminations

 

Total

 

Underwriting income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross premiums written

 

$

55,851

 

$

(1,323

)

 

$

54,528

 

$

235,242

 

$

(11,491

)

$

278,279

 

$

54,528

 

$

235,242

 

$

(11,491

)

$

278,279

 

Reinsurance premiums ceded

 

(49

)

 

 

(49

)

(27,931

)

11,491

 

(16,489

)

(49

)

(27,931

)

11,491

 

(16,489

)

Net premiums written

 

55,802

 

(1,323

)

 

54,479

 

207,311

 

 

261,790

 

54,479

 

207,311

 

 

261,790

 

Change in unearned premiums

 

196,679

 

27,834

 

 

224,513

 

2,043

 

 

226,556

 

224,513

 

2,043

 

 

226,556

 

Net premiums earned

 

252,481

 

26,511

 

 

278,992

 

209,354

 

 

488,346

 

278,992

 

209,354

 

 

488,346

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Underwriting deductions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Losses and loss expenses

 

215,903

 

10,000

 

 

225,903

 

108,926

 

 

334,829

 

225,903

 

108,926

 

40,998

 

334,829

 

Policy acquisition costs

 

39,227

 

3,331

 

(1,093

)

41,465

 

41,160

 

(1,372

)

81,253

 

41,465

 

41,160

 

(1,372

)

81,253

 

General and administrative expenses

 

11,907

 

6,807

 

(5,438

)

13,276

 

30,878

 

8,099

 

52,253

 

12,109

 

30,878

 

9,266

 

52,253

 

Share compensation expenses

 

2,191

 

33

 

196

 

2,420

 

1,934

 

2,883

 

7,237

 

2,191

 

1,934

 

3,112

 

7,237

 

Total underwriting deductions

 

269,228

 

20,171

 

(6,335

)

283,064

 

182,898

 

9,610

 

475,572

 

281,668

 

182,898

 

11,006

 

475,572

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Underwriting (loss) income

 

$

(16,747

)

$

6,340

 

$

6,335

 

$

(4,072

)

$

26,456

 

$

(9,610

)

$

12,774

 

$

(2,676

)

$

26,456

 

$

(11,006

)

$

12,774

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net investment income

 

24,347

 

548

 

 

24,895

 

5,967

 

(2,782

)

28,080

 

24,895

 

5,967

 

(2,782

)

28,080

 

Other income

 

3,358

 

6,068

 

(4,837

)

4,589

 

2,493

 

(3,565

)

3,517

 

3,414

 

2,493

 

(2,390

)

3,517

 

Finance expenses

 

(1,853

)

(1,523

)

 

(3,376

)

(13

)

(10,131

)

(13,520

)

(3,377

)

(13

)

(10,130

)

(13,520

)

Operating income (loss) before taxes

 

9,105

 

11,433

 

1,498

 

22,036

 

34,903

 

(26,088

)

30,851

 

22,256

 

34,903

 

(26,308

)

30,851

 

Tax (expense) benefit

 

(5

)

 

 

(5

)

109

 

122

 

226

 

(5

)

109

 

122

 

226

 

Net operating income (loss) (a)

 

$

9,100

 

$

11,433

 

$

1,498

 

$

22,031

 

$

35,012

 

$

(25,966

)

$

31,077

 

$

22,251

 

$

35,012

 

$

(26,186

)

$

31,077

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net realized gains on investments

 

3,685

 

 

 

3,685

 

1,670

 

 

5,355

 

3,685

 

1,670

 

 

5,355

 

Net unrealized gains (losses) on investments

 

3,898

 

(6

)

 

3,892

 

(1,733

)

 

2,159

 

3,892

 

(1,733

)

 

2,159

 

Foreign exchange (losses) gains

 

(209

)

(139

)

 

(348

)

444

 

170

 

266

 

(348

)

444

 

170

 

266

 

Transaction expenses (c)

 

 

 

 

 

 

(3,850

)

(3,850

)

 

 

(3,850

)

(3,850

)

Net income (loss)

 

$

16,474

 

$

11,288

 

$

1,498

 

$

29,260

 

$

35,393

 

$

(29,646

)

$

35,007

 

$

29,480

 

$

35,393

 

$

(29,866

)

$

35,007

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to noncontrolling interest

 

 

(7,683

)

 

(7,683

)

 

 

(7,683

)

(7,683

)

 

 

(7,683

)

Net income (loss) available to Validus

 

$

16,474

 

$

3,605

 

$

1,498

 

$

21,577

 

$

35,393

 

$

(29,646

)

$

27,324

 

$

21,797

 

$

35,393

 

$

(29,866

)

$

27,324

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selected ratios:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net premiums written / Gross premiums written

 

99.9

%

100.0

%

 

 

 

 

88.1

%

 

 

94.1

%

99.9

%

88.1

%

 

 

94.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Losses and loss expenses

 

85.5

%

37.7

%

 

 

 

 

52.0

%

 

 

68.6

%

81.0

%

52.0

%

 

 

68.6

%

Policy acquisition costs

 

15.5

%

12.6

%

 

 

 

 

19.7

%

 

 

16.6

%

14.9

%

19.7

%

 

 

16.6

%

General and administrative expenses (b)

 

5.6

%

25.8

%

 

 

 

 

15.7

%

 

 

12.2

%

5.1

%

15.7

%

 

 

12.2

%

Expense ratio

 

21.1

%

38.4

%

 

 

 

 

35.4

%

 

 

28.8

%

20.0

%

35.4

%

 

 

28.8

%

Combined ratio

 

106.6

%

76.1

%

 

 

 

 

87.4

%

 

 

97.4

%

101.0

%

87.4

%

 

 

97.4

%

 


Notes:

(a) Net operating income (loss),  a non-GAAP financial measure, is defined as net income (loss) excluding net realized and unrealized gains (losses) on investments, foreign exchange gains (losses) and non-recurring items. This measure focuses on the underlying fundamentals of our operations without the influence of gains (losses) from the sale of investments, translation of non-U.S.$ currencies and non-recurring items. Gains (losses) from the sale of investments are driven by the timing of the disposition of investments, not by our operating performance. Gains (losses) arising from translation of non-U.S.$ denominated balances are unrelated to our underlying business.

 

(b) The general and administrative ratio includes share compensation expenses.

 

(c) The transaction expenses relate to costs incurred in connection with the Company’s proposed acquisition of Transatlantic Holdings, Inc. Transaction expenses are primarily comprised of legal, financial advisory and audit related services.

 

(d) The Validus Re Segment includes the following entities:  Validus Reinsurance, Ltd., Validus Ltd., Validus Reinsurance, Ltd. (Singapore), Validus Reaseguros, Inc., Validus Re Chile S.A., Underwriting Risk Services, S.A., Validus Re Americas, Ltd. and Validus Re Europe Limited.

 

(e) The AlphatCat Segment includes the following entities:  AlphaCat Fund Ltd., AlphaCat Master Fund Ltd. AlphaCat Reinsurance Ltd., AlphaCat High Return Fund Ltd., AlphaCat Re 2011, Ltd., PacRe, Ltd., Validus Underwriting Services, Ltd., Validus Ventures Ltd., and Validus Managers Ltd.

 

(f) On May 25, 2011, the Company joined with other investors in capitalizing AlphaCat Re 2011, Ltd. (“AlphaCat Re 2011”) a new special purpose “sidecar” reinsurer formed for the purpose of writing collateralized reinsurance and retrocessional reinsurance. The financial statements of AlphaCat Re 2011 were included in the consolidated financial statements of the Company beginning in the second quarter of 2011 as Validus Re held a majority of AlphaCat Re 2011’s outstanding voting rights. The portion of AlphaCat Re 2011’s earnings attributable to third party investors for the year ended December 31, 2011 is recorded in the consolidated statement of operations and comprehensive income as ‘net income attributable to noncontrolling interest’. On December 23, 2011 AlphaCat Re 2011 completed a secondary share offering and subsequently Validus Re sold 86,113 shares in AlphaCat Re 2011 and no longer held a majority of the outstanding voting rights and therefore had an equity method investment in AlphaCat Re 2011 as at December 31, 2011.

 

(g) Validus Re Consolidated includes the following entities: Validus Reinsurance, Ltd., Validus Ltd., Validus Reinsurance, Ltd. (Singapore), Validus Specialty, Inc., Validus Reaseguros, Inc., Validus Services, Inc., Validus Re Chile S.A., Validus Re Americas, Ltd., Validus Underwriting Services, Ltd., Validus Re Europe Limited; AlphaCat Fund, Ltd, AlphaCat Master Fund, Ltd., AlphaCat Reinsurance, Ltd., AlphaCat High Return Fund Ltd., AlphaCat Re 2011, Ltd. and PacRe, Ltd.

 

9



 

 

Validus Holdings, Ltd.

Consolidated Segment Income Statement - Year ended December 31, 2011 (REPRESENTED)

(Expressed in thousands of U.S. Dollars, except share and per share information)

 

 

 

Year Ended December 31, 2011

 

Year Ended December 31, 2011

 

 

 

Validus Re
Segment (d)

 

AlphaCat
Segment 
(e)(f)

 

Legal Entity
Adjustments

 

Validus Re
Consolidated (g)

 

Talbot Segment

 

Corporate &
Eliminations

 

Total

 

Validus Re

 

Talbot

 

Corporate &
Eliminations

 

Total

 

Underwriting income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross premiums written

 

$

1,114,493

 

$

75,727

 

 

$

1,190,220

 

$

1,014,122

 

$

(79,651

)

$

2,124,691

 

$

1,190,220

 

$

1,014,122

 

$

(79,651

)

$

2,124,691

 

Reinsurance premiums ceded

 

(150,718

)

 

 

(150,718

)

(218,174

)

79,651

 

(289,241

)

(150,718

)

(218,174

)

79,651

 

(289,241

)

Net premiums written

 

963,775

 

75,727

 

 

1,039,502

 

795,948

 

 

1,835,450

 

1,039,502

 

795,948

 

 

1,835,450

 

Change in unearned premiums

 

2,150

 

(9,761

)

 

(7,611

)

(25,696

)

 

(33,307

)

(7,611

)

(25,696

)

 

(33,307

)

Net premiums earned

 

965,925

 

65,966

 

 

1,031,891

 

770,252

 

 

1,802,143

 

1,031,891

 

770,252

 

 

1,802,143

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Underwriting deductions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Losses and loss expenses

 

749,305

 

10,000

 

 

759,305

 

485,096

 

 

1,244,401

 

759,305

 

485,096

 

40,998

 

1,244,401

 

Policy acquisition costs

 

154,582

 

7,946

 

(2,394

)

160,134

 

157,334

 

(3,284

)

314,184

 

160,134

 

157,334

 

(3,284

)

314,184

 

General and administrative expenses

 

45,199

 

10,929

 

(1,658

)

54,470

 

117,482

 

25,545

 

197,497

 

46,353

 

117,482

 

33,662

 

197,497

 

Share compensation expenses

 

9,309

 

107

 

982

 

10,398

 

8,582

 

15,316

 

34,296

 

9,309

 

8,582

 

16,405

 

34,296

 

Total underwriting deductions

 

958,395

 

28,982

 

(3,070

)

984,307

 

768,494

 

37,577

 

1,790,378

 

975,101

 

768,494

 

46,783

 

1,790,378

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Underwriting income (loss)

 

$

7,530

 

$

36,984

 

$

3,070

 

$

47,584

 

$

1,758

 

$

(37,577

)

$

11,765

 

$

56,790

 

$

1,758

 

$

(46,783

)

$

11,765

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net investment income

 

93,248

 

3,245

 

 

96,493

 

25,380

 

(9,577

)

112,296

 

96,492

 

25,380

 

(9,576

)

112,296

 

Other income

 

7,926

 

11,466

 

(6,017

)

13,375

 

8,895

 

(16,552

)

5,718

 

7,998

 

8,895

 

(11,175

)

5,718

 

Finance expenses

 

(7,777

)

(3,659

)

 

(11,436

)

(227

)

(43,154

)

(54,817

)

(10,289

)

(227

)

(44,301

)

(54,817

)

Operating income (loss) before taxes

 

100,927

 

48,036

 

(2,947

)

146,016

 

35,806

 

(106,860

)

74,962

 

150,991

 

35,806

 

(111,835

)

74,962

 

Tax (expense)

 

(18

)

 

 

(18

)

(651

)

(155

)

(824

)

(18

)

(651

)

(155

)

(824

)

Net operating income (loss) (a)

 

$

100,909

 

$

48,036

 

$

(2,947

)

$

145,998

 

$

35,155

 

$

(107,015

)

$

74,138

 

$

150,973

 

$

35,155

 

$

(111,990

)

$

74,138

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net realized gains on investments

 

21,138

 

531

 

 

21,669

 

6,863

 

 

28,532

 

21,669

 

6,863

 

 

28,532

 

Net unrealized (losses) on investments

 

(14,698

)

(1,341

)

 

(16,039

)

(3,952

)

 

(19,991

)

(16,039

)

(3,952

)

 

(19,991

)

Foreign exchange (losses) gains

 

(19,524

)

(464

)

 

(19,988

)

(2,188

)

52

 

(22,124

)

(19,987

)

(2,188

)

51

 

(22,124

)

Transaction expenses (c)

 

 

 

 

 

 

(17,433

)

(17,433

)

 

 

(17,433

)

(17,433

)

Net income (loss)

 

$

87,825

 

$

46,762

 

$

(2,947

)

$

131,640

 

$

35,878

 

$

(124,396

)

$

43,122

 

$

136,616

 

$

35,878

 

$

(129,372

)

$

43,122

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to noncontrolling interest

 

 

(21,793

)

 

(21,793

)

 

 

(21,793

)

(21,793

)

 

 

(21,793

)

Net income (loss) available to Validus

 

$

87,825

 

$

24,969

 

$

(2,947

)

$

109,847

 

$

35,878

 

$

(124,396

)

$

21,329

 

$

114,823

 

$

35,878

 

$

(129,372

)

$

21,329

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selected ratios:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net premiums written / Gross premiums written

 

86.5

%

100.0

%

 

 

 

 

78.5

%

 

 

86.4

%

87.3

%

78.5

%

 

 

86.4

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Losses and loss expenses

 

77.6

%

15.2

%

 

 

 

 

63.0

%

 

 

69.1

%

73.6

%

63.0

%

 

 

69.1

%

Policy acquisition costs

 

16.0

%

12.0

%

 

 

 

 

20.4

%

 

 

17.4

%

15.5

%

20.4

%

 

 

17.4

%

General and administrative expenses (b)

 

5.6

%

16.7

%

 

 

 

 

16.4

%

 

 

12.9

%

5.4

%

16.4

%

 

 

12.9

%

Expense ratio

 

21.6

%

28.7

%

 

 

 

 

36.8

%

 

 

30.3

%

20.9

%

36.8

%

 

 

30.3

%

Combined ratio

 

99.2

%

43.9

%

 

 

 

 

99.8

%

 

 

99.4

%

94.5

%

99.8

%

 

 

99.4

%

 


Notes:

(a) Net operating income (loss),  a non-GAAP financial measure, is defined as net income (loss) excluding net realized and unrealized gains (losses) on investments, foreign exchange gains (losses) and non-recurring items. This measure focuses on the underlying fundamentals of our operations without the influence of gains (losses) from the sale of investments, translation of non-U.S.$ currencies and non-recurring items. Gains (losses) from the sale of investments are driven by the timing of the disposition of investments, not by our operating performance. Gains (losses) arising from translation of non-U.S.$ denominated balances are unrelated to our underlying business.

 

(b) The general and administrative ratio includes share compensation expenses.

 

(c) The transaction expenses relate to costs incurred in connection with the Company’s proposed acquisition of Transatlantic Holdings, Inc. Transaction expenses are primarily comprised of legal, financial advisory and audit related services.

 

(d) The Validus Re Segment includes the following entities:  Validus Reinsurance, Ltd., Validus Ltd., Validus Reinsurance, Ltd. (Singapore), Validus Reaseguros, Inc., Validus Re Chile S.A., Underwriting Risk Services, S.A., Validus Re Americas, Ltd. and Validus Re Europe Limited.

 

(e) The AlphatCat Segment includes the following entities:  AlphaCat Fund Ltd., AlphaCat Master Fund Ltd. AlphaCat Reinsurance Ltd., AlphaCat High Return Fund Ltd., AlphaCat Re 2011, Ltd., PacRe, Ltd., Validus Underwriting Services, Ltd., Validus Ventures Ltd., and Validus Managers Ltd.

 

(f) On May 25, 2011, the Company joined with other investors in capitalizing AlphaCat Re 2011, Ltd. (“AlphaCat Re 2011”) a new special purpose “sidecar” reinsurer formed for the purpose of writing collateralized reinsurance and retrocessional reinsurance. The financial statements of AlphaCat Re 2011 were included in the consolidated financial statements of the Company beginning in the second quarter of 2011 as Validus Re held a majority of AlphaCat Re 2011’s outstanding voting rights. The portion of AlphaCat Re 2011’s earnings attributable to third party investors for the year ended December 31, 2011 is recorded in the consolidated statement of operations and comprehensive income as ‘net income attributable to noncontrolling interest’. On December 23, 2011 AlphaCat Re 2011 completed a secondary share offering and subsequently Validus Re sold 86,113 shares in AlphaCat Re 2011 and no longer held a majority of the outstanding voting rights and therefore had an equity method investment in AlphaCat Re 2011 as at December 31, 2011.

 

(g) Validus Re Consolidated includes the following entities: Validus Reinsurance, Ltd., Validus Ltd., Validus Reinsurance, Ltd. (Singapore), Validus Specialty, Inc., Validus Reaseguros, Inc., Validus Services, Inc., Validus Re Chile S.A., Validus Re Americas, Ltd., Validus Underwriting Services, Ltd., Validus Re Europe Limited; AlphaCat Fund, Ltd, AlphaCat Master Fund, Ltd., AlphaCat Reinsurance, Ltd., AlphaCat High Return Fund Ltd., AlphaCat Re 2011, Ltd. and PacRe, Ltd.

 

10